Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure

Cardiovascular Research

Volumn 65, Issue 4, 2005, Pages 869-878

  Qvigstad, Eirik ^a   Brattelid, Trond ^a,b   Sjaastad, Ivar ^a,c   Andressen, Kjetil Wessel ^a,b   Krobert, Kurt A ^a,b   Birkeland, Jon Arne ^a   Sejersted, Ole M ^a   Kaumann, Alberto J ^d   Skomedal, Tor ^a   Osnes, Jan Bjørn ^a   Levy, Finn Olav ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

5 HT4 receptor; Contractile function; Heart failure; Serotonin (5 HT); Ventricle

Indexed keywords

1 (4 AMINO 5 CHLORO 2 METHOXYPHENYL) 3 [1 [2 (METHANESULFONAMIDO)ETHYL] 4 PIPERIDINYL] 1 PROPANONE; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; ADENYLATE CYCLASE; CARBACHOL; CYCLIC AMP; ISOPRENALINE; MESSENGER RNA; SEROTONIN; SEROTONIN 4 AGONIST; SEROTONIN 4 RECEPTOR; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART CONTRACTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART PAPILLARY MUSCLE; HEART VENTRICLE; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CARDIOTONIC AGENTS; CYCLIC AMP; HEART FAILURE, CONGESTIVE; INDOLES; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PAPILLARY MUSCLES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN, 5-HT4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SULFONAMIDES;

EID: 13844256361     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.11.017     Document Type: Article

References (44)

1. E. Braunwald, and M.R. Bristow Congestive heart failure: fifty years of progress Circulation 102 2000 IV14 IV23
2. M.R. Bristow β-adrenergic receptor blockade in chronic heart failure Circulation 101 2000 558 569
3. M. Chandra, V. Gupta, A.K. Johri, R. Misra, A. Kumar, and V. Gujrati Serotonergic mechanisms in heart failure Indian Heart J. 46 1994 153 156
4. V.A. Vizir, and A.E. Berezin Relationship between myocardial remodeling and neurohumoral activation in patients with cardiac failure Klin. Med. (Mosk.) 79 2001 21 27
5. W.H. Frishman, and P. Grewall Serotonin and the heart Ann. Med. 32 2000 195 209
6. s protein-coupled receptors in human heart T. Kenakin J.A. Angus The pharmacology of functional, biochemical, and recombinant receptor systems 2000 Springer-Verlag Berlin 73 116
7. A.J. Kaumann, L. Sanders, A.M. Brown, K.J. Murray, and M.J. Brown A 5-hydroxytryptamine receptor in human atrium Br. J. Pharmacol. 100 1990 879 885
8. 4 receptors in the brain and periphery 1998 Springer Berlin 127 148
9. D. Hoyer, D.E. Clarke, J.R. Fozard, P.R. Hartig, G.R. Martin, and E.J. Mylecharane International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin) Pharmacol. Rev. 46 1994 157 203
10. 4 mRNA in heart failure Naunyn-Schmiedeberg's Arch. Pharmacol. 370 2004 157 166
11. S. Läer, F. Remmers, H. Scholz, B. Stein, F.U. Müller, and J. Neumann Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium Br. J. Pharmacol. 123 1998 1182 1188
12. 4 receptors mediate arrhythmias? Trends Pharmacol. Sci. 15 1994 451 455
13. 4 receptor antagonist RS-100302 in experimental atrial flutter and fibrillation Circulation 100 1999 2010 2017
14. 4 receptor: molecular cloning and pharmacological characterization of two splice variants EMBO J. 14 1995 2806 2815
15. U. Jahnel, J. Rupp, R. Ertl, and H. Nawrath Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle Naunyn- Schmiedeberg's Arch. Pharmacol. 346 1992 482 485
16. R.G. Schoemaker, X.Y. Du, W.A. Bax, E. Bos, and P.R. Saxena 5-Hydroxytryptamine stimulates human isolated atrium but not ventricle Eur. J. Pharmacol. 230 1993 103 105
17. 4 receptors, present in piglet atria and sensitive to SDZ 205-557, are absent in papillary muscle Eur. J. Pharmacol. 229 1992 105 108
18. R.G. Schoemaker, X.Y. Du, W.A. Bax, and P.R. Saxena 5-Hydroxytryptamine increases contractile force in porcine right atrium but not in left ventricle Naunyn-Schmiedeberg's Arch. Pharmacol. 346 1992 486 489
19. 4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle Naunyn-Schmiedeberg's Arch. Pharmacol. 363 2001 146 160
20. 4(i) Naunyn-Schmiedeberg's Arch. Pharmacol. 369 2004 616 628
21. H. Selye, E. Bajusz, S. Grasso, and P. Mendell Simple techniques for the surgical occlusion of coronary vessels in the rat Angiology 11 1960 398 407
22. M.A. Pfeffer, J.M. Pfeffer, M.C. Fishbein, P.J. Fletcher, J. Spadaro, and R.A. Kloner Myocardial infarct size and ventricular function in rats Circ. Res. 44 1979 503 512
23. I. Sjaastad, O.M. Sejersted, A. Ilebekk, and R. Bjørnerheim Echocardiographic criteria for detection of postinfarction congestive heart failure in rats J. Appl. Physiol. 89 2000 1445 1454
24. 1- vs. β-adrenoceptor-mediated inotropic response in rats with congestive heart failure Acta Physiol. Scand. 177 2003 449 458
25. T. Skomedal, K. Borthne, H. Aass, O. Geiran, and J.B. Osnes Comparison between alpha-1 adrenoceptor-mediated and beta adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle J. Pharmacol. Exp. Ther. 280 1997 721 729
26. 7 receptor antagonist Br. J. Pharmacol. 130 2000 539 548
27. 3H-cAMP) ligand, or of unlabeled ligand only Acta Pharm. Toxicol. (Copenh) 46 1980 200 204
28. S.A. Bustin Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays J. Mol. Endocrinol. 25 2000 169 193
29. J.B. Osnes, and I. Øye Adenosine 3′,5′-cyclic monophosphate in perfused rat hearts exposed to isoprenaline and dopamine Acta Physiol. Scand. 96 1976 100 113
30. P.J. England Studies on the phosphorylation of the inhibitory subunit of troponin during modification of contraction in perfused rat heart Biochem. J. 160 1976 295 304
31. S.V. Perry The regulation of contractile activity in muscle Biochem. Soc. Trans. 7 1979 593 617
32. J.L. Garvey, E.G. Kranias, and R.J. Solaro Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts Biochem. J. 249 1988 709 714
33. 4 receptors in guinea-pig and rat brain Br. J. Pharmacol. 109 1993 618 624
34. 4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo Br. J. Pharmacol. 115 1995 1387 1392
35. 4 receptor population in piglet right atrium: functional relevance Br. J. Pharmacol. 115 1995 933 936
36. 2- adrenoceptors in human atrium: functional implications Naunyn-Schmiedeberg's Arch. Pharmacol. 353 1996 592 595
37. L.L. Brunton, J.S. Hayes, and S.E. Mayer Functional compartmentation of cyclic AMP and protein kinase in heart Adv. Cycl. Nucleotide Res. 14 1981 391 397
38. I.L. Buxton, and L.L. Brunton Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes J. Biol. Chem. 258 1983 10233 10239
39. H. Aass, T. Skomedal, and J.B. Osnes Increase of cyclic AMP in subcellular fractions of rat heart muscle after beta-adrenergic stimulation: prenalterol and isoprenaline caused different distribution of bound cyclic AMP J. Mol. Cell. Cardiol. 20 1988 847 860
40. 4 receptor isoforms produced by alternative splicing in the carboxyl terminus J. Neurochem. 70 1998 2252 2261
41. D.L. Mann, R.L. Kent, B. Parsons, and G. Cooper Adrenergic effects on the biology of the adult mammalian cardiocyte Circulation 85 1992 790 804
42. 1-adrenergic receptor transgenic mice Proc. Natl. Acad. Sci. U. S. A. 96 1999 7059 7064
43. D.E. Vatner, K. Asai, M. Iwase, Y. Ishikawa, R.P. Shannon, and C.J. Homcy Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart Am. J. Cardiol. 83 1999 80H 85H
44. R. Correa-Araujo, J.S. Oliveira, and C.A. Ricciardi Cardiac levels of norepinephrine, dopamine, serotonin and histamine in Chagas' disease Int. J. Cardiol. 31 1991 329 336